Monoclonal antibody towards H1N1 influenza virus hemagglutinin cross reacts with hnRNPA1 and hnRNPA2/B1
Human Lambda Light Chain |
|||
7-05499 | CHI Scientific | 10mg | Ask for price |
Lambda Light chain Antibody |
|||
43108-100ul | SAB | 100ul | EUR 302.4 |
lambda light chain Antibody |
|||
abx034778-400ul | Abbexa | 400 ul | EUR 627.6 |
lambda light chain Antibody |
|||
abx034778-80l | Abbexa | 80 µl | EUR 343.2 |
Lambda Light chain Antibody |
|||
DF14068 | Affbiotech | 100ul | EUR 420 |
Lambda Light Chain Antibody |
|||
V8873-100UG | NSJ Bioreagents | 100ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody |
|||
V8873-20UG | NSJ Bioreagents | 20ug | EUR 219 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody |
|||
V8873SAF-100UG | NSJ Bioreagents | 100ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkins lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain (Lambda-IgLC) Antibody |
|||
abx413204-02mg | Abbexa | 0.2 mg | EUR 678 |
Lambda Light Chain (Lambda-IgLC) Antibody |
|||
abx414083-025mg | Abbexa | 0.25 mg | EUR 678 |
Lambda Light Chain (Lambda-IgLC) Antibody |
|||
abx415391-01mg | Abbexa | 0.1 mg | EUR 610.8 |
Lambda Light Chain (Lambda-IgLC) Antibody |
|||
abx415790-1mg | Abbexa | 1 mg | EUR 526.8 |
Lambda Light Chain (Lambda-IgLC) Antibody |
|||
abx415793-05mg | Abbexa | 0.5 mg | EUR 477.6 |
Lambda Light Chain (Lambda-IgLC) Antibody |
|||
abx415798-1mg | Abbexa | 1 mg | EUR 661.2 |
Lambda Light Chain (Lambda-IgLC) Antibody |
|||
abx415800-05mg | Abbexa | 0.5 mg | EUR 477.6 |
Lambda Light Chain (Lambda-IgLC) Antibody |
|||
abx411151-1mg | Abbexa | 1 mg | EUR 661.2 |
Lambda Light Chain (Lambda-IgLC) Antibody |
|||
abx411423-05mg | Abbexa | 0.5 mg | EUR 794.4 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20161-100UG | NSJ Bioreagents | 100ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20161BTN-50UG | NSJ Bioreagents | 50ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20161SAF-250UG | NSJ Bioreagents | 250ug | EUR 979 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20179-100UG | NSJ Bioreagents | 100ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20179BTN-50UG | NSJ Bioreagents | 50ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20179SAF-250UG | NSJ Bioreagents | 250ug | EUR 979 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
RQ4975 | NSJ Bioreagents | 100ul | EUR 419 |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V9032-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V9032-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V9032IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V9032SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151CF488-100T | NSJ Bioreagents | 100 Tests | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3152-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3152-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3152SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3261-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm. Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki] |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3261-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm. Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki] |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3261SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm. Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki] |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3262-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3262-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3262SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V2151-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V2151-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V2151SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V2153-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V2153-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V2153CF488-100T | NSJ Bioreagents | 100 Tests | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V2153IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V2153SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V7875-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V7875-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V7875SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V7878-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V7878-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V7878SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V7879-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V7879-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
|||
V7879SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain (Lambda-IgLC) Antibody (FITC) |
|||
abx413205-01mg | Abbexa | 0.1 mg | EUR 610.8 |
Lambda Light Chain (Lambda-IgLC) Antibody (RPE) |
|||
abx413206-100tests | Abbexa | 100 tests | EUR 710.4 |
Lambda Light Chain (Lambda-IgLC) Antibody (HRP) |
|||
abx414084-025mg | Abbexa | 0.25 mg | EUR 710.4 |
Lambda Light Chain (Lambda-IgLC) Antibody (FITC) |
|||
abx415791-1mg | Abbexa | 1 mg | EUR 560.4 |
Lambda Light Chain (Lambda-IgLC) Antibody (HRP) |
|||
abx415792-1ml | Abbexa | 1 ml | EUR 594 |
Lambda Light Chain (Lambda-IgLC) Antibody (FITC) |
|||
abx415794-05mg | Abbexa | 0.5 mg | EUR 526.8 |
Lambda Light Chain (Lambda-IgLC) Antibody (HRP) |
|||
abx415795-1ml | Abbexa | 1 ml | EUR 594 |
Lambda Light Chain (Lambda-IgLC) Antibody (RPE) |
|||
abx415796-05ml | Abbexa | 0.5 ml | EUR 760.8 |
Human Lambda Light Chain (Lambda-IgLC) Protein |
|||
abx670247-1mg | Abbexa | 1 mg | EUR 661.2 |
Human Lambda Light Chain (Lambda-IgLC) Protein |
|||
abx670248-1mg | Abbexa | 1 mg | EUR 777.6 |
Lambda Light Chain (Lambda-IgLC) Antibody (FITC) |
|||
abx411152-1mg | Abbexa | 1 mg | EUR 811.2 |
Lambda Light Chain (Lambda-IgLC) Antibody (TRITC) |
|||
abx411153-05mg | Abbexa | 0.5 mg | EUR 526.8 |
Lambda Light Chain (Lambda-IgLC) Antibody (AP) |
|||
abx411154-1ml | Abbexa | 1 ml | EUR 678 |
Lambda Light Chain (Lambda-IgLC) Antibody (HRP) |
|||
abx411155-1ml | Abbexa | 1 ml | EUR 594 |
Lambda Light Chain (Lambda-IgLC) Antibody (Biotin) |
|||
abx411156-1mg | Abbexa | 1 mg | EUR 727.2 |
Lambda Light Chain (Lambda-IgLC) Antibody (TRITC) |
|||
abx411220-1mg | Abbexa | 1 mg | EUR 560.4 |
Lambda Light Chain (Lambda-IgLC) Antibody (Biotin) |
|||
abx411222-1mg | Abbexa | 1 mg | EUR 594 |
Lambda Light Chain (Lambda-IgLC) Antibody (RPE) |
|||
abx411223-05mg | Abbexa | 0.5 mg | EUR 927.6 |
Rabbit Lambda light chain antibody |
|||
70R-10680 | Fitzgerald | 1 ml | EUR 417.6 |
Description: Rabbit polyclonal Lambda light chain antibody |
Human Lambda Light Chain protein |
|||
31R-1090 | Fitzgerald | 500 ug | EUR 360 |
Description: Purified Human Lambda Light Chain |
Ig lambda Light Chain Antibody |
|||
20-abx137078 | Abbexa |
|
|
Free lambda Light Chain Antibody |
|||
abx023820-1mg | Abbexa | 1 mg | EUR 718.8 |
Lambda Light Chain(HP6054) Antibody |
|||
BNC040262-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF405S conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC040262-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF405S conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC040636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF405S conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC040636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF405S conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC040860-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF405S conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC040860-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF405S conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC050262-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF405M conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC050262-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF405M conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC050636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF405M conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC050636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF405M conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC050860-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF405M conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC050860-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF405M conjugate, Concentration: 0.1mg/mL |
Anti-Human Lambda Light Chain |
|||
DB-039-0.1 | DB Biotech | 100 μl | EUR 254.4 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
Anti-Human Lambda Light Chain |
|||
DB-039-0.2 | DB Biotech | 200 μl | EUR 357.6 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
Anti-Human Lambda Light Chain |
|||
DB-039-0.5 | DB Biotech | 500 μl | EUR 460.8 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
Anti-Human Lambda Light Chain |
|||
DB-039-1 | DB Biotech | 1 ml | EUR 735.6 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
Anti-Human Lambda Light Chain |
|||
DB-039-RTU-15 | DB Biotech | 15 ml | EUR 424.8 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
Anti-Human Lambda Light Chain |
|||
DB-039-RTU-7 | DB Biotech | 7 ml | EUR 277.2 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
Anti-Human Lambda Light Chain |
|||
DB039RTU-15 | DB Biotech | 15 ml | EUR 424.8 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
Anti-Human Lambda Light Chain |
|||
DB039RTU-7 | DB Biotech | 7 ml | EUR 277.2 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
Lambda Light Chain(HP6054) Antibody |
|||
BNCAP0262-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNCAP0262-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNCAP0636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNCAP0636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNCAP0860-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNCAP0860-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNCB0262-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), Biotin conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNCB0262-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), Biotin conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNCB0636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), Biotin conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNCB0636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), Biotin conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNCB0860-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), Biotin conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNCB0860-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), Biotin conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNCP0262-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against Lambda Light Chain(HP6054), PerCP conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNCP0636-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against Lambda Light Chain(LAM03), PerCP conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNCP0860-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against Lambda Light Chain(Lamb14), PerCP conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNCR0262-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against Lambda Light Chain(HP6054), RPE conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNCR0636-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against Lambda Light Chain(LAM03), RPE conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNCR0860-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against Lambda Light Chain(Lamb14), RPE conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC940262-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF594 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC940262-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF594 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC940636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF594 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC940636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF594 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC940860-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF594 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC940860-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF594 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNCA0262-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against Lambda Light Chain(HP6054), APC conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNCA0636-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against Lambda Light Chain(LAM03), APC conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNCA0860-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against Lambda Light Chain(Lamb14), APC conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC810262-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF680R conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC810262-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF680R conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC810636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF680R conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC810636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF680R conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC810860-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF680R conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC810860-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF680R conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNUB0262-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), Concentration: 0.2mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNUB0262-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against Lambda Light Chain(HP6054), Concentration: 0.2mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNUB0636-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), Concentration: 0.2mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNUB0636-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against Lambda Light Chain(LAM03), Concentration: 0.2mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNUB0860-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), Concentration: 0.2mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNUB0860-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against Lambda Light Chain(Lamb14), Concentration: 0.2mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNCH0262-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNCH0262-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNCH0636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNCH0636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNCH0860-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNCH0860-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC880262-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF488A conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC880262-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF488A conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC880636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF488A conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC880636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF488A conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC880860-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF488A conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC880860-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF488A conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC680262-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF568 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC680262-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF568 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC680636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF568 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC680636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF568 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC680860-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF568 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC680860-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF568 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC470262-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF647 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(HP6054) Antibody |
|||
BNC470262-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(HP6054), CF647 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC470636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF647 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC470636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF647 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC470860-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF647 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(Lamb14) Antibody |
|||
BNC470860-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(Lamb14), CF647 conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC400636-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF640R conjugate, Concentration: 0.1mg/mL |
Lambda Light Chain(LAM03) Antibody |
|||
BNC400636-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against Lambda Light Chain(LAM03), CF640R conjugate, Concentration: 0.1mg/mL |
Novel Monoclonal Antibodies Concentrating on the RRM2 area of Human TDP-43 Protein
anti-SOX30 |
|||
YF-PA17405 | Abfrontier | 50 ul | EUR 435.6 |
Description: Mouse polyclonal to SOX30 |
anti-SOX30 |
|||
YF-PA17406 | Abfrontier | 50 ug | EUR 435.6 |
Description: Mouse polyclonal to SOX30 |
anti-SOX30 |
|||
YF-PA17407 | Abfrontier | 100 ul | EUR 483.6 |
Description: Rabbit polyclonal to SOX30 |
anti-SOX30 |
|||
YF-PA17408 | Abfrontier | 100 ug | EUR 483.6 |
Description: Rabbit polyclonal to SOX30 |
Sox30 ORF Vector (Mouse) (pORF) |
|||
ORF058199 | ABM | 1.0 ug DNA | EUR 607.2 |
SOX30 Rabbit pAb |
|||
A11715-100ul | Abclonal | 100 ul | EUR 369.6 |
SOX30 Rabbit pAb |
|||
A11715-200ul | Abclonal | 200 ul | EUR 550.8 |
SOX30 Rabbit pAb |
|||
A11715-20ul | Abclonal | 20 ul | EUR 219.6 |
SOX30 Rabbit pAb |
|||
A11715-50ul | Abclonal | 50 ul | EUR 267.6 |
SOX30 Rabbit pAb |
|||
A11759-100ul | Abclonal | 100 ul | EUR 369.6 |
SOX30 Rabbit pAb |
|||
A11759-200ul | Abclonal | 200 ul | EUR 550.8 |
SOX30 Rabbit pAb |
|||
A11759-20ul | Abclonal | 20 ul | EUR 219.6 |
SOX30 Rabbit pAb |
|||
A11759-50ul | Abclonal | 50 ul | EUR 267.6 |
SOX30 Polyclonal Antibody |
|||
27563-100ul | SAB | 100ul | EUR 302.4 |
SOX30 Polyclonal Antibody |
|||
27563-50ul | SAB | 50ul | EUR 224.4 |
SOX30 Polyclonal Antibody |
|||
27570-100ul | SAB | 100ul | EUR 302.4 |
SOX30 Polyclonal Antibody |
|||
27570-50ul | SAB | 50ul | EUR 224.4 |
SOX30 cloning plasmid |
|||
CSB-CL022430HU-10ug | Cusabio | 10ug | EUR 890.4 |
Description: A cloning plasmid for the SOX30 gene. |
Recombinant human SOX30 |
|||
P2459 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human SOX30 |
Anti-SOX30 antibody |
|||
STJ113314 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein acts as a transcriptional regulator when present in a complex with other proteins. It can activate p53 transcription to promote tumor cell apoptosis in lung cancer. The protein may be involved in the differentiation of developing male germ cells. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 5. |
Anti-SOX30 antibody |
|||
STJ117051 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein acts as a transcriptional regulator when present in a complex with other proteins. It can activate p53 transcription to promote tumor cell apoptosis in lung cancer. The protein may be involved in the differentiation of developing male germ cells. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 5. |
Anti-SOX30 antibody |
|||
STJ117993 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein acts as a transcriptional regulator when present in a complex with other proteins. It can activate p53 transcription to promote tumor cell apoptosis in lung cancer. The protein may be involved in the differentiation of developing male germ cells. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 5. |
Anti-SOX30 (1A11) |
|||
YF-MA17582 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to SOX30 |
Anti-SOX30 (6H1) |
|||
YF-MA17583 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to SOX30 |
pCMV-SPORT6-SOX30 |
|||
PVT18152 | Lifescience Market | 2 ug | EUR 309.6 |
Sox30 sgRNA CRISPR Lentivector set (Mouse) |
|||
K4040301 | ABM | 3 x 1.0 ug | EUR 406.8 |
Polyclonal SOX30 Antibody (Center) |
|||
APR05736G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX30 (Center). This antibody is tested and proven to work in the following applications: |
Human SOX30 shRNA Plasmid |
|||
20-abx957561 | Abbexa |
|
|
SOX30 Polyclonal Conjugated Antibody |
|||
C27563 | SAB | 100ul | EUR 476.4 |
SOX30 Polyclonal Conjugated Antibody |
|||
C27570 | SAB | 100ul | EUR 476.4 |
SOX30 Antibody, HRP conjugated |
|||
1-CSB-PA022430LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against SOX30. Recognizes SOX30 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
SOX30 Antibody, FITC conjugated |
|||
1-CSB-PA022430LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against SOX30. Recognizes SOX30 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
SOX30 Antibody, Biotin conjugated |
|||
1-CSB-PA022430LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against SOX30. Recognizes SOX30 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
SOX30 Recombinant Protein (Human) |
|||
RP029722 | ABM | 100 ug | Ask for price |
Sox30 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K4040302 | ABM | 1.0 ug DNA | EUR 184.8 |
Sox30 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K4040303 | ABM | 1.0 ug DNA | EUR 184.8 |
Sox30 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K4040304 | ABM | 1.0 ug DNA | EUR 184.8 |
SOX30 Protein Vector (Mouse) (pPB-C-His) |
|||
PV232794 | ABM | 500 ng | EUR 1278 |
SOX30 Protein Vector (Mouse) (pPB-N-His) |
|||
PV232795 | ABM | 500 ng | EUR 1278 |
SOX30 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV232796 | ABM | 500 ng | EUR 1278 |
SOX30 Protein Vector (Mouse) (pPM-C-His) |
|||
PV232797 | ABM | 500 ng | EUR 1278 |
Polyclonal SOX30 antibody - middle region |
|||
APR00604G | Leading Biology | 0.05mg | EUR 633.6 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SOX30 - middle region. This antibody is tested and proven to work in the following applications: |
SOX30 ORF Vector (Human) (pORF) |
|||
ORF009908 | ABM | 1.0 ug DNA | EUR 114 |
Mouse Transcription factor SOX- 30, Sox30 ELISA KIT |
|||
ELI-46190m | Lifescience Market | 96 Tests | EUR 1038 |
Transcription Factor SOX-30 (SOX30) Antibody |
|||
20-abx126624 | Abbexa |
|
|
Transcription Factor SOX-30 (SOX30) Antibody |
|||
abx032772-400ul | Abbexa | 400 ul | EUR 627.6 |
Transcription Factor SOX-30 (SOX30) Antibody |
|||
abx032772-80l | Abbexa | 80 µl | EUR 343.2 |
Transcription Factor SOX-30 (SOX30) Antibody |
|||
abx027670-400ul | Abbexa | 400 ul | EUR 627.6 |
Transcription Factor SOX-30 (SOX30) Antibody |
|||
abx027670-80l | Abbexa | 80 µl | EUR 343.2 |
SOX30 sgRNA CRISPR Lentivector set (Human) |
|||
K2261801 | ABM | 3 x 1.0 ug | EUR 406.8 |
Sox30 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K4040305 | ABM | 3 x 1.0 ug | EUR 451.2 |
SOX30 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K2261802 | ABM | 1.0 ug DNA | EUR 184.8 |
SOX30 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K2261803 | ABM | 1.0 ug DNA | EUR 184.8 |
SOX30 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K2261804 | ABM | 1.0 ug DNA | EUR 184.8 |
SOX30 Protein Vector (Human) (pPB-C-His) |
|||
PV039629 | ABM | 500 ng | EUR 394.8 |
SOX30 Protein Vector (Human) (pPB-N-His) |
|||
PV039630 | ABM | 500 ng | EUR 394.8 |
SOX30 Protein Vector (Human) (pPM-C-HA) |
|||
PV039631 | ABM | 500 ng | EUR 394.8 |
SOX30 Protein Vector (Human) (pPM-C-His) |
|||
PV039632 | ABM | 500 ng | EUR 394.8 |
Sox30 3'UTR GFP Stable Cell Line |
|||
TU270992 | ABM | 1.0 ml | Ask for price |
Sox30 3'UTR Luciferase Stable Cell Line |
|||
TU220992 | ABM | 1.0 ml | Ask for price |
Sox30 3'UTR GFP Stable Cell Line |
|||
TU169489 | ABM | 1.0 ml | Ask for price |
SOX30 3'UTR GFP Stable Cell Line |
|||
TU074351 | ABM | 1.0 ml | EUR 1672.8 |
Sox30 3'UTR Luciferase Stable Cell Line |
|||
TU119489 | ABM | 1.0 ml | Ask for price |
SOX30 3'UTR Luciferase Stable Cell Line |
|||
TU024351 | ABM | 1.0 ml | EUR 1672.8 |
Sox30 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K4040306 | ABM | 1.0 ug DNA | EUR 200.4 |
Sox30 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K4040307 | ABM | 1.0 ug DNA | EUR 200.4 |
Sox30 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K4040308 | ABM | 1.0 ug DNA | EUR 200.4 |
Human Transcription factor SOX- 30, SOX30 ELISA KIT |
|||
ELI-29103h | Lifescience Market | 96 Tests | EUR 988.8 |
SOX30 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K2261805 | ABM | 3 x 1.0 ug | EUR 451.2 |
SOX30 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K2261806 | ABM | 1.0 ug DNA | EUR 200.4 |
SOX30 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K2261807 | ABM | 1.0 ug DNA | EUR 200.4 |
SOX30 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K2261808 | ABM | 1.0 ug DNA | EUR 200.4 |
Mouse Monoclonal Antibody |
|||
28297-100Tests | SAB | 100 Tests | EUR 494.4 |
Mouse Monoclonal Antibody |
|||
28297-25Tests | SAB | 25 Tests | EUR 250.8 |
Mouse Monoclonal Antibody |
|||
28298-100Tests | SAB | 100 Tests | EUR 598.8 |
Mouse Monoclonal Antibody |
|||
28298-25Tests | SAB | 25 Tests | EUR 294 |
PCNA Mouse Monoclonal Antibody |
|||
37978-100ul | SAB | 100ul | EUR 302.4 |
PCNA Mouse Monoclonal Antibody |
|||
37978-50ul | SAB | 50ul | EUR 224.4 |
EGFR Mouse Monoclonal Antibody |
|||
37996-100ul | SAB | 100ul | EUR 302.4 |
EGFR Mouse Monoclonal Antibody |
|||
37996-50ul | SAB | 50ul | EUR 224.4 |
CD20 Mouse Monoclonal Antibody |
|||
38003-100ul | SAB | 100ul | EUR 302.4 |
CD20 Mouse Monoclonal Antibody |
|||
38003-50ul | SAB | 50ul | EUR 224.4 |
CD23 Mouse Monoclonal Antibody |
|||
38004-100ul | SAB | 100ul | EUR 302.4 |
CD23 Mouse Monoclonal Antibody |
|||
38004-50ul | SAB | 50ul | EUR 224.4 |
CD68 Mouse Monoclonal Antibody |
|||
38005-100ul | SAB | 100ul | EUR 302.4 |
CD68 Mouse Monoclonal Antibody |
|||
38005-50ul | SAB | 50ul | EUR 224.4 |
CK19 Mouse Monoclonal Antibody |
|||
38006-100ul | SAB | 100ul | EUR 302.4 |
CK19 Mouse Monoclonal Antibody |
|||
38006-50ul | SAB | 50ul | EUR 224.4 |
p53 Mouse Monoclonal Antibody |
|||
38007-100ul | SAB | 100ul | EUR 302.4 |
p53 Mouse Monoclonal Antibody |
|||
38007-50ul | SAB | 50ul | EUR 224.4 |
CK7 Mouse Monoclonal Antibody |
|||
38009-100ul | SAB | 100ul | EUR 302.4 |
CK7 Mouse Monoclonal Antibody |
|||
38009-50ul | SAB | 50ul | EUR 224.4 |
CK8 Mouse Monoclonal Antibody |
|||
38010-100ul | SAB | 100ul | EUR 302.4 |
CK8 Mouse Monoclonal Antibody |
|||
38010-50ul | SAB | 50ul | EUR 224.4 |
CK16 Mouse Monoclonal Antibody |
|||
38011-100ul | SAB | 100ul | EUR 302.4 |
CK16 Mouse Monoclonal Antibody |
|||
38011-50ul | SAB | 50ul | EUR 224.4 |
CDX2 Mouse Monoclonal Antibody |
|||
38012-100ul | SAB | 100ul | EUR 302.4 |
CDX2 Mouse Monoclonal Antibody |
|||
38012-50ul | SAB | 50ul | EUR 224.4 |
GFAP Mouse Monoclonal Antibody |
|||
38014-100ul | SAB | 100ul | EUR 302.4 |
GFAP Mouse Monoclonal Antibody |
|||
38014-50ul | SAB | 50ul | EUR 224.4 |
CD21 Mouse Monoclonal Antibody |
|||
38015-100ul | SAB | 100ul | EUR 302.4 |
CD21 Mouse Monoclonal Antibody |
|||
38015-50ul | SAB | 50ul | EUR 224.4 |
NSE Mouse Monoclonal Antibody |
|||
38021-100ul | SAB | 100ul | EUR 302.4 |
NSE Mouse Monoclonal Antibody |
|||
38021-50ul | SAB | 50ul | EUR 224.4 |
MAP2 Mouse Monoclonal Antibody |
|||
38022-100ul | SAB | 100ul | EUR 302.4 |
MAP2 Mouse Monoclonal Antibody |
|||
38022-50ul | SAB | 50ul | EUR 224.4 |
ABCB5 Mouse Monoclonal Antibody |
|||
38031-100ul | SAB | 100ul | EUR 302.4 |
ABCB5 Mouse Monoclonal Antibody |
|||
38031-50ul | SAB | 50ul | EUR 224.4 |
ERCC1 Mouse Monoclonal Antibody |
|||
38035-100ul | SAB | 100ul | EUR 302.4 |
ERCC1 Mouse Monoclonal Antibody |
|||
38035-50ul | SAB | 50ul | EUR 224.4 |
CK17 Mouse Monoclonal Antibody |
|||
38038-100ul | SAB | 100ul | EUR 302.4 |
CK17 Mouse Monoclonal Antibody |
|||
38038-50ul | SAB | 50ul | EUR 224.4 |
CD23 Mouse Monoclonal Antibody |
|||
38039-100ul | SAB | 100ul | EUR 302.4 |
CD23 Mouse Monoclonal Antibody |
|||
38039-50ul | SAB | 50ul | EUR 224.4 |
EFHD1 Mouse Monoclonal Antibody |
|||
38043-100ul | SAB | 100ul | EUR 302.4 |
EFHD1 Mouse Monoclonal Antibody |
|||
38043-50ul | SAB | 50ul | EUR 224.4 |
HSV Mouse Monoclonal Antibody |
|||
38056-100ul | SAB | 100ul | EUR 302.4 |
HSV Mouse Monoclonal Antibody |
|||
38056-50ul | SAB | 50ul | EUR 224.4 |
HSP90β Mouse Monoclonal Antibody |
|||
38066-100ul | SAB | 100ul | EUR 302.4 |
HSP90β Mouse Monoclonal Antibody |
|||
38066-50ul | SAB | 50ul | EUR 224.4 |
PARP Mouse Monoclonal Antibody |
|||
38067-100ul | SAB | 100ul | EUR 302.4 |
PARP Mouse Monoclonal Antibody |
|||
38067-50ul | SAB | 50ul | EUR 224.4 |
EGFR Mouse Monoclonal Antibody |
|||
38070-100ul | SAB | 100ul | EUR 302.4 |
EGFR Mouse Monoclonal Antibody |
|||
38070-50ul | SAB | 50ul | EUR 224.4 |
eIF4A1 Mouse Monoclonal Antibody |
|||
38072-100ul | SAB | 100ul | EUR 302.4 |
eIF4A1 Mouse Monoclonal Antibody |
|||
38072-50ul | SAB | 50ul | EUR 224.4 |